Actinium Pharmaceuticals, Inc.
Pharmaceutical company · New York, United States · NYSE: ATNM
Actinium Pharmaceuticals, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on NYSE under the ticker ATNM. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.1 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $6.6 million sold in a notice filed in 2014.
What does Actinium Pharmaceuticals do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.1 million in total (2020 to 2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $6.6 million sold (2014).
Frequently asked questions about Actinium Pharmaceuticals
Where is Actinium Pharmaceuticals headquartered?
Actinium Pharmaceuticals, Inc. is headquartered in New York, United States.
What does Actinium Pharmaceuticals do?
Actinium Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Actinium Pharmaceuticals a public company?
Yes. Actinium Pharmaceuticals, Inc. trades on NYSE under the ticker ATNM.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
- SELLAS Life Sciences Group, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.